Janus Henderson Group plc (JHG) 13D/13G Filings for Dyne Therapeutics, Inc. (DYN)

Janus Henderson Group plc 13D and 13G filings for Dyne Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-17
4:34 pm
Sale
2025-12-3113GDyne Therapeutics, Inc.
DYN
JANUS HENDERSON GROUP PLC
JHG
13,887,722
8.500%
-857,783decrease
(-5.82%)
Filing
2025-11-14
11:58 am
Purchase
2025-09-3013GDyne Therapeutics, Inc.
DYN
JANUS HENDERSON GROUP PLC
JHG
14,745,505
10.400%
350,506increase
(+2.43%)
Filing
2025-08-07
10:34 am
Purchase
2025-07-3113GDyne Therapeutics, Inc.
DYN
JANUS HENDERSON GROUP PLC
JHG
14,394,999
10.100%
4,041,124increase
(+39.03%)
Filing
2025-05-14
12:16 pm
Purchase
2025-03-3113GDyne Therapeutics, Inc.
DYN
JANUS HENDERSON GROUP PLC
JHG
10,353,875
9.200%
2,974,566increase
(+40.31%)
Filing
2025-02-14
12:22 pm
Purchase
2024-12-3113GDyne Therapeutics, Inc.
DYN
JANUS HENDERSON GROUP PLC
JHG
7,379,309
7.300%
566,146increase
(+8.31%)
Filing
2024-11-14
10:28 am
Purchase
2024-09-3013GDyne Therapeutics, Inc.
DYN
JANUS HENDERSON GROUP PLC
JHG
6,813,163
6.800%
6,813,163increase
(New Position)
Filing